The purpose of this study was to determine the effects of pregnancy an
d oral contraceptive use on in vivo coagulation by measurement of plas
ma levels of prothrombin fragment 1+2 and thrombin antithrombin III co
mplex. Fifty-four women with uncomplicated singleton gestations, 34 wo
men using oral contraceptives and 45 nonpregnant controls were the sub
jects of this study. Levels of prothrombin fragment 1+2 and thrombin-a
ntithrombin III complex were measured using enzyme linked immunoassays
. In uncomplicated pregnancies, levels of prothrombin fragment 1+2 and
thrombin antithrombin III complex increased significantly with advanc
ing gestational age. Women using oral contraceptives had significantly
higher levels of prothrombin fragment 1+2 and thrombin antithrombin I
II complex compared to non-pregnant controls. The significant increase
in levels of prothrombin fragment 1+2 and thrombin-antithrombin III c
omplex throughout gestation and in women using oral contraceptives pro
vided evidence of thrombin activation during these clinical conditions
.